Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain

NCT05771103 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.

NCT NCT05771103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05771103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain
Lead sponsor
National Cancer Institute, Egypt
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2023
Completion date
July 30, 2023
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-mastectomy pain syndrome